Navigation Links
Maryland's Cancer Care Community, Patient Advocates Urge State Legislature to Create Parity in Coverage for Preferred Cancer Drugs
Date:2/6/2012

ANNAPOLIS, Md., Feb. 3, 2012 /PRNewswire-USNewswire/ -- Citing the significant quality of life benefits that oral chemotherapy drugs can provide over intravenously (IV) administered chemotherapy, Maryland's cancer community, patient advocacy representatives and patients themselves called on the state legislature this week to pass key legislation that would ensure Maryland's cancer patients are able to access their prescribed chemotherapy regimen of choice.

IV chemotherapy can lead to side effects including pain, hair loss, nausea, vomiting, and anemia, and can lead to added costs and logistical issues as patients must travel to cancer care facilities for treatment. Although oral chemotherapy drugs taken at home often result in fewer side effects, many health insurance plans' coverage of orally administered chemotherapy is prohibitive due to higher copays, expensive deductibles or restrictive coverage limits.

"Oral chemotherapy drugs can often provide substantially greater comfort and convenience than IV administered chemotherapy, and Maryland's cancer patients should have access to the treatments they prefer," said Nancy Davenport-Ennis, founder and CEO of the National Patient Advocate Foundation (NPAF) and the Patient Advocate Foundation (PAF). "We urge Maryland's legislature to create parity in coverage and help individuals fighting cancer access the chemotherapy treatment of their choice without cost being an unrealistic barrier."

The Kathleen A. Mathias Chemotherapy Parity Act of 2012 (Senate Bill 179) would prohibit insurers, nonprofit health service plans, and health maintenance organizations (HMOs) from covering orally administered cancer chemotherapy on terms that are less favorable than coverage for IV administered cancer chemotherapy. The bill is named in honor of the late Kathy Mathias, wife of Sen. Jim Mathias (D-38), who lost her 14-year battle with cancer last August. The legislation currently has 26 cosponsor
'/>"/>

SOURCE National Patient Advocate Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others
2. New Study of Primary Liver Cancer Seeks to Enroll 400 French Patients
3. FDA Approves New Skin Cancer Drug First Tested in Arizona by Scottsdale Healthcare and TGen
4. FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer
5. Precision Therapeutics Enhances Their Straightforward Approach to Personalizing Cancer Care
6. OncoSec to Present at World Cancer Immunotherapy Conference
7. Signal Genetics Announces Publication of Meta-Analysis of its Colon Cancer Test-Previstage™ GCC Confirming Prognostic Capabilities in Patients with Colon Cancer
8. VentiRx Pharmaceuticals Publishes Preclinical Data of Novel TLR8 Agonist, VTX-2337, Supporting Its Potential as an Immunotherapeutic Approach in Cancer
9. Varian Medical Systems Showcases Advanced Radiotherapy Systems for Treating Cancer at 2012 Arab Health Congress and Exhibition
10. OncoGenex Announces Presentation of OGX-427 Data at the ASCO 2012 Genitourinary Cancers Symposium
11. Phase III Data Show Bayers Investigational Compound Regorafenib (BAY 73-4506) Met Primary Endpoint Showing Statistically Significant Improvement in Overall Survival in Patients with Metastatic Colorectal Cancer Refractory to Standard Approved Thera
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 2015  InMed Pharmaceuticals Inc. ("InMed") (CSE: IN; ... specializes in developing safer, more effective cannabis-based therapies, ... Anderson , Ph.D., to its Scientific Advisory Board.  ... brings significant drug discovery and development expertise to ... organic chemist by training with more than 30 ...
(Date:3/31/2015)... 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... 150mg, 225mg and 300mg oral tablets, indicated for use ... market for Propafenone Hydrochloride 150mg, 225mg and 300mg tablets ... Arthur S. Przybyl , President and Chief ... launch of our fourth product from the portfolio of ...
(Date:3/31/2015)... , March 31, 2015  Oxis International, Inc. ... therapy development and commercialization, announced today Oxis CEO ... trading of Oxis common shares on the Euronext exchange. ... under the symbol OXIS.   Oxis Chairman ... continues to move forward with its strategies launched in ...
Breaking Medicine Technology:InMed Pharmaceuticals Strengthens Scientific Advisory Board 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 3InMed Pharmaceuticals Strengthens Scientific Advisory Board 4ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Oxis International Inc. Announces Request for Euronext Trading Suspension 2
... PALO ALTO, Calif., Dec. 20, 2010 Huntsman Gay ... today announced the completion of a recapitalization of Sunquest ... systems. The recapitalization, led by Huntsman Gay, was done ... the company since 2007 and is retaining a significant ...
... Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: ... senior vice president and corporate controller, has been named ... immediately, replacing Peggy Mulligan, former chief financial officer, who ... interests.  The Company has initiated a search to identify ...
Cached Medicine Technology:Huntsman Gay-Led Consortium Completes Recapitalization of Sunquest Information Systems 2Huntsman Gay-Led Consortium Completes Recapitalization of Sunquest Information Systems 3Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO 2Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO 3
(Date:3/31/2015)... (PRWEB) March 31, 2015 Array ... exchange technology, has announced that Lance Hood, Senior Director ... Consumerism Private Exchange Forum on April 1, 2015. The ... of Benaissance, will address how employers can streamline and ... , WHAT: “ Optimizing Employee and Employer Needs ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 The ... Health Care Administrators (ACHCA) elected two administrators from ... and long-term care in New Jersey, to two ... of new officers. Robert Reyes, administrator for Abingdon ... elected president, and Yael Herman, administrator of Canterbury ...
(Date:3/31/2015)... 2015 As a family owned and operated ... good teacher when it comes to raising their children. In ... service to the community, Metro Express Service is launching a ... area teachers can be too cool for school. , “We ... in to help our children get a head start in ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 DataEntryOutsourced ... professional team of data entry experts to handle the ... tasked with managing a complex nutritional scoring system for ... a free trial of their nutrition scale data entry ... — "A Case Study on U.S. Food Nutrition Scale ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 ... Latinos offered by the VisitandCare.com company, announced today ... Puerto Vallarta. , Embracing the most experienced and ... patients are traveling to obtain elegant, life-altering cosmetic ... seeking reputable plastic surgery clinics in Mexico due ...
Breaking Medicine News(10 mins):Health News:Array Health’s Senior Director of Marketing to Co-Present with Benaissance at The Institute for HealthCare Consumerism Private Exchange Forum 2Health News:Abingdon Care & Rehabilitation Center’s Administrator Elected President of N.J. Chapter of the American College of Health Care Administrators 2Health News:Metro Express Service Launches Educator Discount Program to DFW Teachers 2Health News:DEO Announces a Team of Dedicated Data Entry Operators for Nutrition Score Data Entry 2Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 2Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 3Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 4
... identified high levels of a number of genes in the ... other rodents and demonstrate resistance to age-related diseases. The ... of the naked mole-rat - a rodent that lives for ... to understand its longevity and resistance to disease. ...
... , When Nancy Grace and her partner danced a lively rumba ... the Stars," more was going on in the legal commentator,s brain ... Grace,s cortex, millions of neurons were hard at work doing what ... partner Tristan MacManus,s movements to create a pas de deux that ...
... , THURSDAY, Nov. 3 (HealthDay News) --,A new ... more effective and less costly than primary care-based ... of Birmingham researchers compared weight loss among obese ... weight-loss programs that lasted 12 weeks (Weight Watchers, ...
... Smokers are more likely to kick the habit after a ... was damaged by the stroke, researchers say. The study ... they had a stroke were much more likely to be ... These findings may lead to new ways to personalize ...
... Steven Reinberg HealthDay Reporter , THURSDAY, Nov. 3 ... increasing their risk for cancer, just as the time they ... "For colon and breast cancer we can now say ... risk of developing those two major cancers," said Christine ...
... has long been known that cancer cells use nutrients differently ... field of cancer metabolism has shed new light on the ... demonstrating that manipulation of an enzyme called PKM2 is important ... by a scientific team at Beth Israel Deaconess Medical Center ...
Cached Medicine News:Health News:Scientists identify genes that may signal long life in naked mole-rats 2Health News:It takes two: Brains come wired for cooperation, neuroscientist asserts 2Health News:Weighing Weight-Loss Programs 2Health News:Some Smokers More Likely to Quit After Stroke Than Others 2Health News:Too Much Sitting Raises Odds for Cancer: Study 2Health News:Too Much Sitting Raises Odds for Cancer: Study 3Health News:Too Much Sitting Raises Odds for Cancer: Study 4Health News:Study identifies an expanded role for PKM2 in helping cancer cells survive 2Health News:Study identifies an expanded role for PKM2 in helping cancer cells survive 3